NCT03767582: An ongoing trial by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
This trial is ongoing. It must report results 3 months, 1 week from now.
Full data
| Full entry on ClinicalTrials.gov | NCT03767582 |
|---|---|
| Title | A Phase I/II Trial of Combination Immunotherapy With Nivolumab and a CCR2/CCR5 Dual Antagonist (BMS-813160) With or Without GVAX Following Chemotherapy and Radiotherapy for Locally Advanced Pancreatic Ductal Adenocarcinomas (PDACs). |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Dec. 12, 2019 |
| Completion date | Sept. 30, 2024 |
| Required reporting date | Sept. 30, 2025, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | June 20, 2025 |
| Days late | None |